Foundation Venture Capital Group, LLC β Full Portfolio
15 tracked investments Β· listed companies and verified rows first
NovoPedics is developing MeniscoFix, a resorbable implant placed via arthroscopically-assisted surgery to replace the entire medial or lateral meniscus of the knee, intended to relieve pain, restore mobility, and prevent osteoarthritis in patients with severe meniscal injuries.
BiotechHealthtechMedical DevicesMonmouth Junction, US
Charles J. Gatt, Jr., MD(Founder & CEO)Michael G. Dunn, PhD(Founder & Secretary/Treasurer)Kevin Weadock, PhD(Chief Operating Officer)
Zena Therapeutics is a therapeutics company developing drug candidates, with work spanning molecular design, pharmacology, animal studies, and clinical trial design toward IND submission.
BiotechHealthtechMental HealthPrinceton, US
Eileen Carry, PhD(Founder)inEileen Carry(Chief Scientific Officer | co-Founder)Ariane Vasilatis(Chief Executive Officer | co-Founder)
Biopharmaceutical company developing Leukothera-based therapeutics for blood cancers, autoimmune/inflammatory diseases, and HIV.
BiotechKendall Park, US
BENJAMIN BELINKA(Executive Officer, Director)JAMES GOLUBIESKI(Director)PETER ALFF(Director)SCOTT KACHLANY(Director)
Developing blood tests to detect neurodegenerative diseases at early stages; Foundation sold its equity interest to Breakthrough Diagnostics, LLC.
Durin Technologies (Durin Life Sciences) develops Duritect blood tests that combine autoantibody biomarkers with machine learning to assess a patient's risk of Alzheimer's disease and Parkinson's disease.
AI & Machine LearningBiotechDigital Health
First spin-out from Hackensack Meridian Health Research Institute, developing a platform for targeted capture of extracellular vesicles to enable earlier detection of tumors and other diseases.
Kayo Therapeutics is a biotechnology company developing therapeutics, with a scientific and clinical focus that includes areas such as metabolic disease and oncology.
BiotechHealthtechSeattle, US
Mark Esposito(CSO, Co-Founder and Board Member)inYibin Kang(Chair, Scientific Advisory Board and Co-Founder)Kendall Mohler(Executive Officer, Director)Thong Q. Le(President and CEO, Board Member)Ian Howes(Chief Financial Officer)Merika Koday(COO and Board Member)in
Co-investors7G BioVentures
Focused on longevity technologies; Foundation sold its equity interest to Rostock International, Ltd.
Co-investorsXploration Capital
Repurposing a clinically approved drug to treat L-Dopa Induced Dyskinesia in Parkinson's disease patients.
NemaGen Discoveries develops first-in-class therapies targeting mast cell-related diseases and chronic inflammation by leveraging insights from studying the body's natural inflammatory response to parasitic infections.
BiotechDigital HealthHealthtechMedical Devices
Mark(Associate Professor in the Department of Medicine and the Center for Immunity and Inflammation at Rutgers New Jersey Medical School)Martin(Chief Executive Officer)
Spinout of Cooper University HealthCare developing a multi-directional vascular access system enabling antegrade and retrograde access through a single entry point.
Designs mental health and addiction medications aimed at minimizing misuse and preventing overdose fatalities.
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.